{"name":"Eric Bernicker, MD","slug":"eric-bernicker-md","ticker":"","exchange":"","domain":"","description":"Eric Bernicker, MD is a biopharmaceutical company focused on the development of innovative therapies, though it currently has no active drug candidates in its pipeline as both top drugs have been discontinued.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Alsertib","genericName":"Alsertib","slug":"alsertib","indication":"Other","status":"discontinued"}]}],"pipeline":[{"name":"Alsertib","genericName":"Alsertib","slug":"alsertib","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE1fZmxxcy0wZ0xxMV9pTUdhRjFnRVI4UzF0bFd6QXpEanJJd1plTEVWb3Q1RlJ3bzQ5dkYtY1gtMVpHSENEOHRDMkt3STFySElYdmVzdll4SQ?oc=5","date":"2023-11-27","type":"pipeline","source":"ASCO Publications","summary":"Climate Change and Cancer Care: A Policy Statement From ASCO - ASCO Publications","headline":"Climate Change and Cancer Care: A Policy Statement From ASCO","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"discontinued":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}